Health X Platform Ltd Q2 FY26 Results & Concall Highlights: Revenue, Margins & Order Book
Published 26 May 2026 | Healthcare Services | Market Cap: ₹977 Cr
Sastasundar aims to achieve INR 500 crore annual run rate in B2C (Sastasundar app) within 18 months. RetailerShakti is expected to be EBITDA positive by Q4 FY26 and achieve around 1% EBITDA margin in FY26.
From Health X Platform Ltd's Q2 FY26 earnings-call transcript · updated 23 Aug 2026.
Price
₹301
Market Cap
₹977 Cr
P/E Ratio
508.6
How does Health X Platform Ltd rank in Healthcare Services?
Compare Health X Platform Ltd against every Healthcare Services company this quarter on revenue, margins and earnings-call signals.
Health X Platform Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹346 Cr, net profit ₹0 Cr.
Full financials →📊 Revenue & Sales Performance
- →Sastasundar aims to achieve INR 500 crore annual run rate in B2C (Sastasundar app) within 18 months.
- →RetailerShakti is expected to grow rapidly at over 30% CAGR over the next 2-3 years, targeting INR 4,000 crore revenue by 2030.
- →Overall company revenue target for FY '29-'30 is INR ~6,000 crore (INR 4,000 crore from RetailerShakti and INR 2,000 crore from B2C).
- →HealthBuddy network to expand from current 260 to about 360 within 18 months, targeting INR 1 crore sales per HealthBuddy annually.
- →Working capital efficiency will improve, aiming to reduce working capital to 3%-4% of revenue in 3-5 years, improving liquidity and scalability.
- →Profitability: RetailerShakti breakeven expected by Q4 FY '26 with 1% EBITDA margin by FY '26; B2C EBITDA-positive by FY '28-'29.
- →Expansion focused on Eastern and Northern India over next 3+ years before entering Western and Southern states strategically.
📈 Profitability & Margins
- →RetailerShakti is expected to be EBITDA positive by Q4 FY26 and achieve around 1% EBITDA margin in FY26.
- →Sastasundar B2C aims to be contribution margin positive next year (covering variable costs) and EBITDA positive by FY28-FY29.
- →The company plans sustained profitable growth with RetailerShakti growing over 30% CAGR over the next 2-3 years.
- →By FY29-FY30, revenue target is INR2,930 crores with about 4-5% EBITDA margin.
- →Sastasundar app revenue is projected to reach INR500 crores annual run rate within 18 months.
- →Working capital efficiency to improve, reducing from 6-7% of revenue to around 3-4% in 3-5 years, enhancing profitability.
- →The firm targets doubling capital every 2 years, aiming for 50-60% return on capital employed in 4-5 years.
- →Internal accruals and treasury income will fund growth; no external capital planned for next 5 years.
🏗️ Capital Expenditure Plans
- →Current/future capex primarily focused on technology, AI development, warehouse automation, and satellite warehouse expansion.
- →Planned capex amount around INR 40-50 crores annually, funded comfortably through internal accruals and treasury income (INR 400+ crores available).
- →No plans to raise external capital for at least next 5 years.
- →Automation at fulfillment centers aims to double fulfillment capacity and reduce costs.
- →Building new warehouses strategically (e.g., Udaipur) to expand geographical reach gradually without hurried capital deployment.
- →Investment in AI-enabled retailer app rollout for next 6-8 months to improve inventory management and order automation.
- →Overall capital-efficient business model with high returns on capital employed and breakeven expected soon in key segments.
💰 Fundraising & Capital Structure
- →SastaSundar Ventures Limited does not plan any external capital raise in the near future.
- →The company currently has a treasury of approximately INR 400 crores, which generates around INR 40-50 crores in income.
- →This treasury income is planned to fund technology expansion, warehouse expansion, and other investments.
- →The company expects to remain PAT positive after covering these expenses through treasury income.
- →There is no foreseeable need to raise debt or equity for at least the next 5 years.
📋 Order Book & Pipeline
Key Metrics
Frequently Asked Questions
What were Health X Platform Ltd Q2 FY26 results?
Sastasundar aims to achieve INR 500 crore annual run rate in B2C (Sastasundar app) within 18 months. RetailerShakti is expected to be EBITDA positive by Q4 FY26 and achieve around 1% EBITDA margin in FY26.
What is Health X Platform Ltd share price analysis?
Health X Platform Ltd currently shows a neutral. The stock trades at a P/E of 508.6 with a market cap of ₹977 Cr. Investors should review the full earnings analysis for detailed insights.
Is Health X Platform Ltd planning capital expenditure?
Current/future capex primarily focused on technology, AI development, warehouse automation, and satellite warehouse expansion.
Keep Health X Platform Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.